{"id":"NCT00982228","sponsor":"Novo Nordisk A/S","briefTitle":"Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Aspart in Type 1 Diabetes","officialTitle":"NN1250-3583: A 52 Week Randomised, Controlled, Open Label, Multicentre, Multinational, Parallel, Treat-to-target Trial Comparing Efficacy and Safety of SIBA and Insulin Glargine Both Administered Once Daily in a Basal-bolus Regimen With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes (BEGIN™: BB T1 LONG) / NN1250-3644: An Extension Trial to Trial NN1250-3583 Comparing Safety and Efficacy of NN1250 With Insulin Glargine, Both With Insulin Aspart as Meal-time Insulin, in Type 1 Diabetes (BEGIN™: T1)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-09-01","primaryCompletion":"2010-11-08","completion":"2010-11-08","firstPosted":"2009-09-23","resultsPosted":"2015-12-29","lastUpdate":"2017-04-06"},"enrollment":629,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 1"],"interventions":[{"type":"DRUG","name":"insulin degludec","otherNames":[]},{"type":"DRUG","name":"insulin glargine","otherNames":[]},{"type":"DRUG","name":"insulin aspart","otherNames":[]}],"arms":[{"label":"IDeg OD","type":"EXPERIMENTAL"},{"label":"IGlar OD","type":"ACTIVE_COMPARATOR"}],"summary":"This trial is conducted in Africa, Europe and the United States of America (USA).\n\nThe aim of the trial is to compare NN1250 (insulin degludec, soluble insulin basal analogue (SIBA)) plus insulin aspart with insulin glargine (IGlar) plus insulin aspart in patients with type 1 diabetes.\n\nThe main period is registered internally at Novo Nordisk as NN1250-3583 while the extension period is registered as NN1250-3644.","primaryOutcome":{"measure":"Main Trial (Primary Endpoint): Change in Glycosylated Haemoglobin (HbA1c) After 52 Weeks of Treatment","timeFrame":"Week 0, Week 52","effectByArm":[{"arm":"IDeg OD","deltaMin":-0.4,"sd":0.73},{"arm":"IGlar OD","deltaMin":-0.39,"sd":0.84}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":6},"locations":{"siteCount":91,"countries":["United States","France","Germany","Russia","South Africa","United Kingdom"]},"refs":{"pmids":["23130654","26484727","24170235","26121451","26232910","25081590","24812526","22521071","28210866"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":71,"n":472},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Headache","Sinusitis","Influenza"]}}